BONESUPPORT - CERAMENT® G Approved by Health Canada
Lund, Sweden, 18:00 CET, 16 August 2018 - BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, announces that its antibiotic-eluting product CERAMENT G has been approved by Health Canada. CERAMENT G is the first and only CE-marked gentamicin-eluting injectable ceramic bone graft substitute on the market. CERAMENT G sales have been growing strongly based on the clinical benefits it delivers when used for indications where infection may be present or of concern. BONESUPPORT is currently conducting the FORTIFY trial to assess CERAMENT G’s ability to